Emerging Respiratory Therapeutics Medical Advisor

GSK; Belgique; Hybrid; EUR 74,000 - 123,000; Full time

Job summary

GlaxoSmithKline in Belgium is seeking an Emerging Therapeutics Medical Advisor to connect with healthcare professionals and academic experts. This hybrid medical affairs role focuses on advancing clinical practice, improving patient outcomes, and supporting pre-launch readiness across respiratory programs.

You will apply deep clinical expertise to engage HCPs, communicate medical insights, and collaborate with Medical Affairs, market access, and other teams to ensure a compliant, evidence-based

Qualifications

• Doctorate level with medical/clinical focus (MD/PhD/PharmD) or advanced science/healthcare degree.
• Respiratory therapeutic experience, preferably in Belgium.
• 2+ years Medical Affairs or pre-launch readiness experience.
• Experience engaging with medical professionals and decision makers.
• Fluency in French and English required.

Responsibilities

• Identify and engage HCPs and medical societies to inform medical plans.
• Educate on disease state, trial data, and product information to advance the pipeline.
• Develop and execute medical strategic and tactical plans.
• Collaborate with Medical Affairs, Market Access, Marketing, and Sales to ensure a customer-centric approach.
• Support clinical trials and drive evidence generation activities.

Skills

French

English

Digital Fluency

Enterprise Thinking

External Stakeholder Management

High Impact Communication

Patient Impact

Education

MD/PhD/PharmD or equivalent

Job description

GlaxoSmithKline in Belgium is seeking an Emerging Therapeutics Medical Advisor to connect with healthcare professionals and academic experts. This hybrid medical affairs role focuses on advancing clinical practice, improving patient outcomes, and supporting pre-launch readiness across respiratory programs.

You will apply deep clinical expertise to engage HCPs, communicate medical insights, and collaborate with Medical Affairs, market access, and other teams to ensure a compliant, evidence-based